Senti Biosciences, Inc.
Ticker: 1854270
P/L Snapshot
Q1 FY26 · consolidated
vs Q3 FY23
Revenue
0.02
-92.3%
Expenditure
4.63
-89.5%
Net Profit
-4.22
+71.7%
OPM %
-100.00%
Shareholding
Pattern breakdown
P/L Trends
(in millions)
RevenueExpenditureNet Profit
Price Chart
Latest News
Corporate Events
Board MeetingSNTI
202627Oct
Board Meeting
Edward Mathers resigned from the Board of Directors and its …
SEC Filing ↗ Board MeetingSNTI
202615Oct
Board Meeting
Senti Biosciences Holdings, Inc. reconvened its 2026 Annual …
SEC Filing ↗ Board MeetingSNTI
202623Sep
Board Meeting
Brenda Cooperstone, Ph.D. resigned from the Board of Directo…
SEC Filing ↗